Mengis Capital Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10M | Sell |
40,968
-4
| -0% | -$932 | 1.72% | 14 |
|
|
2025
Q4 | $8.48M | Buy |
40,972
+4,922
| +14% | +$973K | 1.5% | 17 |
|
|
2025
Q3 | $6.68M | Sell |
36,050
-224
| -0.6% | -$38.4K | 1.31% | 17 |
|
|
2025
Q2 | $5.54M | Sell |
36,274
-10,250
| -22% | -$1.58M | 1.18% | 19 |
|
|
2025
Q1 | $7.72M | Sell |
46,524
-2,291
| -5% | -$358K | 1.61% | 15 |
|
|
2024
Q4 | $7.06M | Sell |
48,815
-78
| -0.2% | -$12.1K | 1.44% | 17 |
|
|
2024
Q3 | $7.92M | Sell |
48,893
-3,115
| -6% | -$496K | 1.56% | 16 |
|
|
2024
Q2 | $7.6M | Sell |
52,008
-5,446
| -9% | -$810K | 1.54% | 15 |
|
|
2024
Q1 | $9.09M | Buy |
57,454
+69
| +0.1% | +$11K | 1.4% | 16 |
|
|
2023
Q4 | $8.99M | Sell |
57,385
-160
| -0.3% | -$24.5K | 1.69% | 12 |
|
|
2023
Q3 | $8.96M | Sell |
57,545
-255
| -0.4% | -$42.1K | 1.86% | 11 |
|
|
2023
Q2 | $9.57M | Sell |
57,800
-225
| -0.4% | -$36.3K | 1.91% | 10 |
|
|
2023
Q1 | $8.99M | Sell |
58,025
-213
| -0.4% | -$34.4K | 1.89% | 12 |
|
|
2022
Q4 | $10.3M | Sell |
58,238
-45
| -0.1% | -$7.77K | 2.24% | 9 |
|
|
2022
Q3 | $9.52M | Sell |
58,283
-2,117
| -4% | -$358K | 2.26% | 10 |
|
|
2022
Q2 | $10.7M | Sell |
60,400
-538
| -0.9% | -$95.9K | 2.35% | 9 |
|
|
2022
Q1 | $10.8M | Sell |
60,938
-97
| -0.2% | -$16.5K | 2.07% | 12 |
|
|
2021
Q4 | $10.4M | Buy |
61,035
+1,751
| +3% | +$287K | 1.96% | 10 |
|
|
2021
Q3 | $9.57M | Sell |
59,284
-68
| -0.1% | -$11.6K | 2.01% | 11 |
|
|
2021
Q2 | $9.78M | Buy |
59,352
+2,922
| +5% | +$484K | 2.03% | 10 |
|
|
2021
Q1 | $9.27M | Buy |
56,430
+952
| +2% | +$154K | 2.05% | 10 |
|
|
2020
Q4 | $8.73M | Buy |
55,478
+268
| +0.5% | +$39.5K | 2.12% | 8 |
|
|
2020
Q3 | $8.22M | Sell |
55,210
-161
| -0.3% | -$23.8K | 2.25% | 6 |
|
|
2020
Q2 | $7.79M | Buy |
55,371
+452
| +0.8% | +$65.9K | 2.31% | 5 |
|
|
2020
Q1 | $7.2M | Sell |
54,919
-123
| -0.2% | -$17.5K | 2.46% | 5 |
|
|
2019
Q4 | $8.03M | Sell |
55,042
-363
| -0.7% | -$49.2K | 2.21% | 6 |
|
|
2019
Q3 | $7.17M | Sell |
55,405
-498
| -0.9% | -$65.6K | 2.14% | 6 |
|
|
2019
Q2 | $7.79M | Buy |
55,903
+26,477
| +90% | +$3.66M | 2.38% | 5 |
|
|
2019
Q1 | $4.11M | Sell |
29,426
-519
| -2% | -$69.5K | 2.3% | 9 |
|
|
2018
Q4 | $3.86M | Sell |
29,945
-1,413
| -5% | -$197K | 2.45% | 8 |
|
|
2018
Q3 | $4.33M | Sell |
31,358
-149
| -0.5% | -$19.8K | 2.38% | 7 |
|
|
2018
Q2 | $3.82M | Buy |
31,507
+1,727
| +6% | +$215K | 2.26% | 8 |
|
|
2018
Q1 | $3.82M | Buy |
29,780
+872
| +3% | +$118K | 2.28% | 9 |
|
|
2017
Q4 | $4.04M | Sell |
28,908
-137
| -0.5% | -$19.1K | 2.45% | 9 |
|
|
2017
Q3 | $3.78M | Sell |
29,045
-600
| -2% | -$79.5K | 2.53% | 9 |
|
|
2017
Q2 | $3.92M | Sell |
29,645
-50
| -0.2% | -$6.38K | 2.78% | 6 |
|
|
2017
Q1 | $3.7M | Buy |
29,695
+150
| +0.5% | +$17.9K | 2.71% | 6 |
|
|
2016
Q4 | $3.4M | Sell |
29,545
-940
| -3% | -$109K | 2.71% | 8 |
|
|
2016
Q3 | $3.6M | Sell |
30,485
-680
| -2% | -$82.5K | 3% | 4 |
|
|
2016
Q2 | $3.78M | Sell |
31,165
-300
| -1% | -$34.1K | 3.33% | 2 |
|
|
2016
Q1 | $3.4M | Sell |
31,465
-1,736
| -5% | -$180K | 3.14% | 2 |
|
|
2015
Q4 | $3.41M | Buy |
33,201
+1,201
| +4% | +$121K | 2.97% | 4 |
|
|
2015
Q3 | $2.99M | Buy |
32,000
+1,202
| +4% | +$116K | 2.78% | 4 |
|
|
2015
Q2 | $3M | Sell |
30,798
-198
| -0.6% | -$19.8K | 2.51% | 5 |
|
|
2015
Q1 | $3.12M | Buy |
30,996
+1,801
| +6% | +$183K | 2.72% | 5 |
|
|
2014
Q4 | $3.05M | Buy |
+29,195
| New | +$3.08M | 2.95% | 5 |
|
Other funds holding JNJ
VCM
VPM
Mengis Capital Management's JNJ Position: Q1 2026 in Review
Mengis Capital Management reduced its Johnson & Johnson (JNJ) stake by 0.01% in Q1 2026, selling an estimated $932 and leaving 40,968 shares worth $10M. The position accounts for 1.72% of the portfolio, ranked #14.
Mengis Capital Management first reported a position in JNJ in Q4 2014 and has held it in 46 quarters since. The position peaked at $10.8M in Q1 2022. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Mengis Capital Management held 40,968 shares of Johnson & Johnson worth $10M as of Q1 2026.
- Mengis Capital Management sold 4 Johnson & Johnson shares in Q1 2026, an estimated $932.
- Johnson & Johnson made up 1.72% of Mengis Capital Management's portfolio in Q1 2026, its #14 holding.
- Mengis Capital Management first reported a position in Johnson & Johnson in Q4 2014 and has held it in 46 quarters since.
- Mengis Capital Management's Johnson & Johnson position peaked at $10.8M in Q1 2022.
- 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Mengis Capital Management's 13F filing for Q1 2026, filed 12 May 2026.